Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;162(1):7-8.
doi: 10.1111/jnc.15651. Epub 2022 Jun 14.

Preface to the special issue "Psychedelics and Neurochemistry"

Charles D Nichols  1 , David E Nichols  2
Affiliations
Editorial

Preface to the special issue "Psychedelics and Neurochemistry"

Charles D Nichols et al. J Neurochem. 2022 Jul.

Abstract

Psychedelics are a relatively recent field of research that had not gained much support half a century ago, yet it developed into a much acknowledged, highly relevant field that extends to many people's lives. Psychedelics have demonstrated profound and durable therapeutic potential for the treatment of several psychiatric disorders including depression, anxiety, and substance use disorders, among others. In this special issue, basic science of psychedelics is reviewed with respect to fundamental cellular, molecular, and genetic mechanisms, all the way up to the human systems level with clinical reviews. We hope the articles, authored by leading scientists in their field, will help to understand better the role of the serotonin 5-HT2A receptor in particular in healthy and diseased brain function.

PubMed Disclaimer

References

REFERENCES

    1. Duerler, P., Vollenweider, F. X., Preller, K. H. (2022) A neurobiological perspective on social influence: Serotonin and social adaptation
    1. Gonzalez-Maeso, J., Jaster, A., de la Fuente R. M. (2021) Molecular targets of psychedelic-induced plasticity
    1. Kozlowska, U., Nichols, C., Wiatr, K., Figiel, M. (2021) From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
    1. Pottie, E., Stove, C. (2021) In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR
    1. Reckweg, J., Uthaug, M., Szabo, A., Davis, A., Lancelotta, R., Mason, N., Ramaekers, J. (2022) The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)

Publication types